Therefore, we evaluated the significance of CAND1 expression in ERα-positive breast cancer via bioinformatics analysis of the clinical indicators and survival data in several large online databases, including Bc-GenExMiner and TIMER2.0. This evidence concerns the gene ESR1 and breast carcinoma.